SHARESIFT
Healthcare · data ~15-min delayed
345.7 CHF -0.95%
| Price | 345.7 CHF |
| Day change | -0.95% |
| Market cap | 275.44B |
| 52-week range | 258.2 – 375.8 |
| P/E (trailing) | 22.6 |
| Dividend yield | 2.83% |
| Payout ratio | 63.93% |
| Return on equity | 38.11% |
| Debt / equity | 91% |
| Beta | 0.35 |
| Sector | Healthcare |
| Value score | 30 / 100 |
How the value score is calculated: 13 published tests, weighted to 100.
Roche Holding AG (ROP.SW) scores 30/100 on this site's value model, in the lower band: most of the valuation measures it checks sit on the richer side. It trades at 22.6 times trailing earnings and is classified in Healthcare. The dividend yield is 2.83%, paid from 64% of earnings. Return on equity is 38%, with debt at 91% of equity. On its filings it passes 7 of the nine Piotroski checks, which points to improving fundamentals. Its Altman Z-Score places it in the safe zone. These are automated readings of reported figures, not a recommendation.
Piotroski F-Score 7 / 9 — nine pass/fail checks on profitability, leverage and efficiency, comparing the latest financial year with the one before.
Altman Z-Score 4.67 — Safe zone.
Updated · prices ~15-min delayed, fundamentals as last reported
Open full interactive analysis →Value scoring · Piotroski F-Score · Altman Z · technicals · dividends — free, no sign-up.